- Home
- GTE vs OBIO Comparison
GTE vs OBIO Comparison
Compare GTE & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTE
- OBIO
- Stock Information
- Founded
- GTE 2003
- OBIO 2017
- Country
- GTE Canada
- OBIO United States
- Employees
- GTE N/A
- OBIO N/A
- Industry
- GTE Oil & Gas Production
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- GTE Energy
- OBIO Health Care
- Exchange
- GTE Nasdaq
- OBIO Nasdaq
- Market Cap
- GTE 164.0M
- OBIO 151.3M
- IPO Year
- GTE N/A
- OBIO N/A
- Fundamental
- Price
- GTE $4.40
- OBIO $2.87
- Analyst Decision
- GTE
- OBIO Strong Buy
- Analyst Count
- GTE 0
- OBIO 5
- Target Price
- GTE N/A
- OBIO $14.20
- AVG Volume (30 Days)
- GTE 202.1K
- OBIO 957.1K
- Earning Date
- GTE 05-01-2025
- OBIO 05-16-2025
- Dividend Yield
- GTE N/A
- OBIO N/A
- EPS Growth
- GTE N/A
- OBIO N/A
- EPS
- GTE N/A
- OBIO N/A
- Revenue
- GTE $634,805,000.00
- OBIO $2,638,000.00
- Revenue This Year
- GTE $10.77
- OBIO $13.87
- Revenue Next Year
- GTE N/A
- OBIO $32.19
- P/E Ratio
- GTE N/A
- OBIO N/A
- Revenue Growth
- GTE N/A
- OBIO N/A
- 52 Week Low
- GTE $3.34
- OBIO $2.43
- 52 Week High
- GTE $10.40
- OBIO $8.87
- Technical
- Relative Strength Index (RSI)
- GTE 48.95
- OBIO 47.75
- Support Level
- GTE $3.99
- OBIO $2.37
- Resistance Level
- GTE $4.56
- OBIO $2.88
- Average True Range (ATR)
- GTE 0.21
- OBIO 0.33
- MACD
- GTE -0.00
- OBIO 0.05
- Stochastic Oscillator
- GTE 50.75
- OBIO 57.47
About GTE Gran Tierra Energy Inc.
Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. A majority of its revenue is derived from its operations in Colombia.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.